In contrast, α-PD-L1 induction of these exhaustion markers did not elevate in CD4+ T cells from spleens, demonstrating that reprogramming tumor-infiltrating lymphocytes (TIL) is the key to improved therapeutic outcomes. Here, CD4 is linked to neoplasm.